N-methyl-d-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein
- 24 May 2008
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 55 (2) , 204-214
- https://doi.org/10.1016/j.neuropharm.2008.05.016
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Subunit-Specific Agonist Activity at NR2A-, NR2B-, NR2C-, and NR2D-Containing N-Methyl-d-aspartate Glutamate ReceptorsMolecular Pharmacology, 2007
- Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor functionBiochemical and Biophysical Research Communications, 2007
- HIV-tat induces formation of an LRP–PSD-95– NMDAR–nNOS complex that promotes apoptosis in neurons and astrocytesProceedings of the National Academy of Sciences, 2007
- Differential expression of N‐methyl‐d‐aspartate receptor NR2 isoforms in Alzheimer's diseaseJournal of Neurochemistry, 2004
- Characterization of the Heparin Binding Sites in Human Apolipoprotein EPublished by Elsevier ,2003
- The α-Chains of C4b-binding Protein Mediate Complex Formation with Low Density Lipoprotein Receptor-related ProteinPublished by Elsevier ,2002
- Ligand affinities at recombinant receptors depend on subunit compositionEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTPPharmacology Biochemistry and Behavior, 1991
- Apolipoprotein E polymorphism association with lipoprotein profile in endogenous hypertriglyceridemia and familial hypercholesterolemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Receptor interactions controlling lipoprotein metabolismCanadian Journal of Biochemistry and Cell Biology, 1985